Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Schmechtig A, Lees J, Grayson L, Craig KJ, Dadhiwala R, Dawson GR, Deakin JF, Dourish CT, Koychev I, McMullen K, Migo EM, Perry C, Wilkinson L, Morris R, Williams SC, Ettinger U. Schmechtig A, et al. Among authors: craig kj. Psychopharmacology (Berl). 2013 May;227(2):331-45. doi: 10.1007/s00213-013-2973-4. Epub 2013 Feb 22. Psychopharmacology (Berl). 2013. PMID: 23430159 Clinical Trial.
The effects of ketamine and risperidone on eye movement control in healthy volunteers.
Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, Williams SC, Ettinger U. Schmechtig A, et al. Among authors: craig kj. Transl Psychiatry. 2013 Dec 10;3(12):e334. doi: 10.1038/tp.2013.109. Transl Psychiatry. 2013. PMID: 24326395 Free PMC article. Clinical Trial.
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, Schmechtig A, Walters J, Craig KJ, Dawson GR, Dourish CT, Ettinger U, Wilkinson L, Williams S, Deakin JF, Barkus E. Koychev I, et al. Among authors: craig kj. Eur Neuropsychopharmacol. 2012 Jul;22(7):469-81. doi: 10.1016/j.euroneuro.2011.10.005. Epub 2011 Dec 3. Eur Neuropsychopharmacol. 2012. PMID: 22137565 Clinical Trial.
Alterations in working memory networks in amnestic mild cognitive impairment.
Migo EM, Mitterschiffthaler M, O'Daly O, Dawson GR, Dourish CT, Craig KJ, Simmons A, Wilcock GK, McCulloch E, Jackson SH, Kopelman MD, Williams SC, Morris RG. Migo EM, et al. Among authors: craig kj. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(1):106-27. doi: 10.1080/13825585.2014.894958. Epub 2014 Mar 12. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015. PMID: 24617815
Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI.
Migo EM, O'Daly O, Mitterschiffthaler M, Antonova E, Dawson GR, Dourish CT, Craig KJ, Simmons A, Wilcock GK, McCulloch E, Jackson SH, Kopelman MD, Williams SC, Morris RG. Migo EM, et al. Among authors: craig kj. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016;23(2):196-217. doi: 10.1080/13825585.2015.1073218. Epub 2015 Aug 3. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016. PMID: 26234803
72 results